Profile data is unavailable for this security.
About the company
PANION & BF BIOTECH INC. is a Taiwan-based company principally engaged in the manufacture and sales of western medicines and experimental drugs. The Company is also involved in the manufacture and sales of various kinds of cosmetics. The Company's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The Company also provides biotechnology services. The Company distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.
- Revenue in TWD (TTM)1.88bn
- Net income in TWD77.22m
- Incorporated1976
- Employees321.00
- LocationPanion & BF Biotech Inc16F, Building FNo. 3, Yuanqu Street, Nangang DistrictTAIPEI 115TaiwanTWN
- Phone+886 226558218
- Fax+886 226558318
- Websitehttps://www.pbf.com.tw/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sinphar Pharmaceutical Co Ltd | 2.96bn | 375.17m | 6.21bn | 984.00 | 16.57 | 2.00 | 10.62 | 2.09 | 2.23 | 2.23 | 17.64 | 18.47 | 0.4765 | 2.37 | 6.03 | -- | 5.74 | -0.0147 | 7.76 | -0.0203 | 36.83 | 37.49 | 12.04 | -0.0344 | 1.50 | 16.24 | 0.364 | 79.70 | 3.72 | 5.98 | 67.01 | 111.88 | 3.31 | 58.49 |
| Tanvex Biopharma Inc | 61.41m | -2.14bn | 6.33bn | -- | -- | 6.37 | -- | 103.10 | -16.51 | -16.51 | 0.4711 | 6.06 | 0.0199 | 0.0123 | 12.62 | -- | -69.13 | -49.24 | -77.48 | -53.18 | 97.22 | 49.20 | -3,480.00 | -10,835.34 | 1.36 | -77.72 | 0.6784 | -- | 174.11 | -- | -30.22 | -- | -8.09 | -- |
| China Chemical & Pharmaceutical Co Ltd | 8.76bn | 327.98m | 6.68bn | 1.40k | 20.37 | 0.8929 | 10.15 | 0.762 | 1.10 | 1.10 | 29.36 | 25.09 | 0.6814 | 2.21 | 5.55 | -- | 2.57 | 3.69 | 3.55 | 4.96 | 36.61 | 36.56 | 3.77 | 5.50 | 0.8324 | -- | 0.3172 | 52.77 | 1.40 | 2.50 | -32.51 | -2.72 | 3.57 | -8.97 |
| Panion & BF Biotech Inc | 1.88bn | 77.22m | 8.42bn | 321.00 | 109.10 | 4.41 | 34.00 | 4.47 | 0.9001 | 0.9001 | 21.94 | 22.29 | 0.5947 | 1.67 | 8.19 | -- | 2.44 | 4.08 | 3.55 | 5.63 | 51.78 | 52.37 | 4.10 | 5.93 | 0.8931 | 16.24 | 0.2758 | 111.06 | -21.54 | 5.96 | -57.65 | -13.47 | 35.39 | -3.23 |
| Pell Bio Med Technology Co Ltd | 18.03m | -398.76m | 8.45bn | -- | -- | 6.82 | -- | 468.77 | -8.62 | -8.62 | 0.3898 | 21.71 | 0.0147 | 10.59 | 2.64 | -- | -32.59 | -- | -35.02 | -- | -144.96 | -- | -2,225.03 | -- | 12.58 | -- | 0.1275 | -- | 5.11 | -- | -73.27 | -- | -- | -- |
| SCI Pharmtech Inc | 1.20bn | 294.72m | 11.22bn | 241.00 | 35.53 | 2.20 | 25.50 | 9.32 | 2.64 | 2.64 | 12.87 | 42.67 | 0.2067 | 1.64 | 5.01 | -- | 5.06 | 6.90 | 5.72 | 8.26 | 29.09 | 38.18 | 24.48 | 19.85 | 2.50 | 11.90 | 0.1697 | 42.38 | 33.83 | -9.10 | -4.55 | -8.00 | 44.67 | -16.35 |
Data as of May 20 2024. Currency figures normalised to Panion & BF Biotech Inc's reporting currency: Taiwan Dollar TWD
3.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 09 May 2024 | 2.62m | 3.06% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 489.23k | 0.57% |
| Mellon Investments Corp.as of 09 May 2024 | 113.00k | 0.13% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 53.79k | 0.06% |
| Parametric Portfolio Associates LLCas of 31 Mar 2024 | 19.00k | 0.02% |
| Vanguard Global Advisers LLCas of 30 Apr 2024 | 6.21k | 0.01% |
| DFA Australia Ltd.as of 31 Dec 2023 | 6.09k | 0.01% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 5.01k | 0.01% |
| Irish Life Investment Managers Ltd.as of 09 May 2024 | 2.00k | 0.00% |
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
